Graefen M - Search Results

1

Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.

Isbarn H, Jeldres C, Shariat SF, Liberman D, Sun M, Lughezzani G, Widmer H, Arjane P, Pharand D, Fisch M, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI. Isbarn H, et al. Among authors: graefen m. J Urol. 2009 Nov;182(5):2177-81. doi: 10.1016/j.juro.2009.07.035. Epub 2009 Sep 16. J Urol. 2009. PMID: 19758662

2

Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.

Graefen M, Karakiewicz PI, Cagiannos I, Hammerer PG, Haese A, Palisaar J, Huland E, Scardino PT, Kattan MW, Huland H. Graefen M, et al. J Urol. 2002 Mar;167(3):1306-9. J Urol. 2002. PMID: 11832719

3

Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer.

Graefen M, Karakiewicz PI, Cagiannos I, Klein E, Kupelian PA, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, de Kernion J, Cangiano T, Schröder FH, Wildhagen MF, Scardino PT, Kattan MW. Graefen M, et al. J Clin Oncol. 2002 Feb 15;20(4):951-6. doi: 10.1200/JCO.2002.20.4.951. J Clin Oncol. 2002. PMID: 11844816

4

Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?

Cagiannos I, Graefen M, Karakiewicz PI, Ohori M, Eastham JA, Rabbani F, Fair W, Wheeler TM, Hammerer PG, Haese A, Erbersdobler A, Huland H, Scardino PT, Kattan MW. Cagiannos I, et al. Among authors: graefen m. J Clin Oncol. 2002 Apr 15;20(8):2025-30. doi: 10.1200/JCO.2002.08.123. J Clin Oncol. 2002. PMID: 11956261

5

Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer.

Palisaar RJ, Graefen M, Karakiewicz PI, Hammerer PG, Huland E, Haese A, Fernandez S, Erbersdobler A, Henke RP, Huland H. Palisaar RJ, et al. Among authors: graefen m. Eur Urol. 2002 Feb;41(2):155-61. doi: 10.1016/s0302-2838(01)00025-2. Eur Urol. 2002. PMID: 12074402

6

Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables.

Graefen M, Augustin H, Karakiewicz PI, Hammerer PG, Haese A, Palisaar J, Blonski J, Fernandez S, Erbersdobler A, Huland H. Graefen M, et al. Eur Urol. 2003 Jan;43(1):6-10; discussion 11. doi: 10.1016/s0302-2838(02)00497-9. Eur Urol. 2003. PMID: 12507538

7

Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening.

Aleman M, Karakiewicz PI, Kupelian P, Kattan MW, Graefen M, Cagiannos I, Eastham J, Scardino PT, Huland H, Klein EA. Aleman M, et al. Among authors: graefen m. Urology. 2003 Jul;62(1):70-4. doi: 10.1016/s0090-4295(03)00125-0. Urology. 2003. PMID: 12837425

8

A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.

Cagiannos I, Karakiewicz P, Eastham JA, Ohori M, Rabbani F, Gerigk C, Reuter V, Graefen M, Hammerer PG, Erbersdobler A, Huland H, Kupelian P, Klein E, Quinn DI, Henshall SM, Grygiel JJ, Sutherland RL, Stricker PD, Morash CG, Scardino PT, Kattan MW. Cagiannos I, et al. Among authors: graefen m. J Urol. 2003 Nov;170(5):1798-803. doi: 10.1097/01.ju.0000091805.98960.13. J Urol. 2003. PMID: 14532779

9

Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer.

Augustin H, Eggert T, Wenske S, Karakiewicz PI, Palisaar J, Daghofer F, Huland H, Graefen M. Augustin H, et al. Among authors: graefen m. J Urol. 2004 Jan;171(1):177-81. doi: 10.1097/01.ju.0000099827.77355.a7. J Urol. 2004. PMID: 14665871

10

Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.

Graefen M, Ohori M, Karakiewicz PI, Cagiannos I, Hammerer PG, Haese A, Erbersdobler A, Henke RP, Huland H, Wheeler TM, Slawin K, Scardino PT, Kattan MW. Graefen M, et al. J Urol. 2004 Jan;171(1):200-3. doi: 10.1097/01.ju.0000099161.70713.c8. J Urol. 2004. PMID: 14665876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

951 results

Search Page

Filters